Bridgewater Associates’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$956K Buy
+33,517
New +$1.14M ﹤0.01% 794
2024
Q4
Sell
-19,685
Closed -$552K 699
2024
Q3
$552K Sell
19,685
-20,632
-51% -$509K ﹤0.01% 679
2024
Q2
$918K Sell
40,317
-5,692
-12% -$131K ﹤0.01% 677
2024
Q1
$1.4M Buy
46,009
+25,579
+125% +$857K 0.01% 540
2023
Q4
$729K Sell
20,430
-1,517
-7% -$56.4K ﹤0.01% 673
2023
Q3
$961K Sell
21,947
-38,723
-64% -$1.89M 0.01% 612
2023
Q2
$2.99M Sell
60,670
-4,676
-7% -$216K 0.02% 407
2023
Q1
$2.71M Buy
65,346
+11,732
+22% +$487K 0.02% 416
2022
Q4
$2.38M Sell
53,614
-18,248
-25% -$762K 0.01% 501
2022
Q3
$2.81M Buy
71,862
+93
+0.1% +$4.25K 0.01% 490
2022
Q2
$2.93M Buy
71,769
+6,983
+11% +$331K 0.01% 605
2022
Q1
$4.25M Buy
64,786
+15,930
+33% +$1.03M 0.02% 509
2021
Q4
$3.4M Buy
48,856
+6,926
+17% +$503K 0.02% 380
2021
Q3
$2.92M Sell
41,930
-1,494
-3% -$115K 0.02% 374
2021
Q2
$3.44M Buy
+43,424
New +$3.16M 0.02% 401

Other funds holding ATRC